Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
34 Cards in this Set
- Front
- Back
secondary causes of hypertension (4) |
pheochromocytoma, coarctation, renal vascular dz, adrenal cortical tumors
|
|
tx for mild htn that has minimal compensatory BP responses but can cause hypokalemia, slight hyperlipidemia, hyperuricemia, hyperglycemia, lassitude, weakness and impotence
|
thiazides
|
|
tx for mod-sev HTN that may cause hypokalemia, hypovolemia, and ototoxicity
|
furosemide (loop diuretics)
|
|
MOA of clonidine, methyldopa
|
α2 agonists in CNS to decrease SNS outflow, reduces CO and vascular resistance
|
|
major side effects of α2 agonists?
|
salt/water retention, sedation
clonidine: sudden d/c = rebound HTN methyldopa: positive Coombs, hemolytic anemia |
|
antihypertensive that depletes adrenergic terminal of NE; in low doses has minimal compensatory effect but causes salt/water retention at high dose
|
Reserpine
|
|
antihypertensive that depletes adrenergic terminal of NE AND blocks its release; may cause orthostatic hypotension and sexual dysfxn
|
guanethidine
|
|
most serious toxicity of reserpine?
|
behavioral depression
|
|
a meal high in tyramine may cause a hypertensive crisis in pts on this drug that used to be used for HTN
|
MAO Inhibitors (tyramine causes release of stored NE)
|
|
type of adrenoceptor blocker that reduces vascular resistance and venous return?
|
α1 blocker (prazosin)
|
|
why are phentolamine and phenoxybenzamine not useful in tx of HTN?
|
nonselective α-blockers cause excessive compensatory response, esp tachycardia
|
|
drugs that reduce cardiac output immediately and later also decrease vascular resistance
|
β-blockers
(delayed vasodilation d/t reduction of renin release from kidneys) |
|
major side effects of β-blockers
|
sleep disturbance, sedation, impotence, cardiac disturbance, asthma, elevated LDL/trigs
|
|
drugs that cause release of NO (from endothelium or from drug)
|
nitroprusside, hydralazine
|
|
drugs that cause hyperpolarization of vascular smooth muscle by opening K+ channels
|
minoxidil, diazoxide
|
|
antihypertensive associated with lupus-like syndrome?
|
hydralazine |
|
vasodilators that are more efficacious on arterioles than veins
|
hydralazine, minoxidil
|
|
vasodilator reserved for severe HTN?
|
minoxidil
|
|
toxic effects of minoxidil?
|
severe compensatory responses (salt/water retention and tachycardia), hirsutism, pericardial effusion
|
|
drugs used for chronic tx of HTN of any severity; fewer compensatory responses than hydralazine and minoxidil
|
nifedipine, verapamil, diltiazem
(calcium channel blockers) |
|
adverse effects of nifedipine?
|
constipation, cardiac disturbances, flushing (minor salt/water retention)
|
|
side effects of short-acting drug for HTN emergencies that releases NO to vascular smooth muscle?
|
excessive hypotension, tachycardia, salt/water retention, cyanide and/or thiocyanate poisoning
|
|
antidote for most serious nitroprusside side effect?
|
sodium thiocyanate (cyanide poisoning)
|
|
MOA of diazoxide?
|
Thiazide that lacks diuretic properties; vasodilates by opening K+ channels to hyperpolarize smooth muscle; reduces insulin release
|
|
antihypertensive drug also used in tx of insulinomas?
|
diazoxide
|
|
dopamine D1 receptor agonist with short duration vasodilation used for hypertensive emergencies
|
Fenoldopam
|
|
antihypertensives that increase kinin family vasodilators
|
ACE inhibitors (captopril)
|
|
antihypertensives that may complicate renal artery stenosis and cause renal failure in fetuses, but are protective for the diabetic kidney?
|
ACE inhibitors
|
|
drug used when pt develops dry cough 2/2 ACE-I?
|
Losartan, valsartan (angiotensin receptor blockers)
|
|
drug that inhibits formation of angiotensin I from angiotensinogen
|
aliskiren
|
|
never take potassium supplements or potassium-sparing diuretics with these antihypertensives
|
angiotensin antagonists (losartan)
renin inhibitors (aliskiren) (dec angII -> dec aldosterone -> potassium retention) |
|
steps of care in pharmacologic tx of HTN?
|
1) lifestyle (salt restriction, wt loss)
2) diuretics 3) sympathoplegics (β blocker or α&β blocker) 4) ACE-Is 5) vasodilators (Ca channel blocker) |
|
elderly pts respond better to _____ and ______ than ______
|
β blockers and diuretics than ACE inhibitors
|
|
pharmacological management of malignant HTN?
|
powerful vasodilator (nitroprusside, fenoldopam or diazoxide) with diuretics (furosemide) and β blockers
|